Skip to main content

Lexapro News

Running vs. Meds: Which Works Best to Beat Depression?

MONDAY, Oct. 9, 2023 – Exercise has been dubbed "nature's antidepressant" by doctors for years, and now a new study confirms the notion. The finding follows a four-month look at the impact that...

EEG Model Predicts Response to SSRI Meds in Major Depressive Disorder

THURSDAY, Sept. 28, 2023 – For patients with major depressive disorder, an electroencephalography (EEG)-based model can predict response to selective serotonin reuptake inhibitor (SSRI) medications,...

Prolonged Antidepressant Treatment No Benefit in Bipolar I Disorder

THURSDAY, Aug. 3, 2023 – For patients with bipolar I disorder who had recently had remission of a depressive episode, adjunctive treatment with escitalopram or bupropion XL that continues for 52...

Treating Menopause Symptoms: Medications, Lifestyle & Self-Care

MONDAY, June 19, 2023 – Navigating the changes and discomforts of menopause can be a frustrating experience for many women. Daily life can be significantly affected by symptoms ranging from hot...

The Most Common Depression Medications, Explained

FRIDAY, May 26, 2023 – You've been diagnosed with depression. What's next? The cornerstone of treatment remains antidepressants, so it's likely your doctor will prescribe one for you, but which one...

FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn

Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...

FDA Medwatch Alert: Lexapro (escitalopram oxalate)

[Posted 02/16/2007] FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications online. Individuals who ordered Ambien, Xanax, Lexapro, and...

FDA Medwatch Alert: Lexapro (escitalopram)

[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...

FDA Medwatch Alert: Antidepressant Medication Products

[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...

FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitors (SSRIs) - Serotonin Syndrome

[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...

FDA Medwatch Alert: SSRIs and Treatment Challenges of Depression in Pregnancy

[Posted 07/19/2006] FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women...

FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults

The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Anxiety, Generalized Anxiety Disorder, Major Depressive Disorder, Depression

Lexapro patient information at Drugs.com